Change in serum 25-hydroxyvitamin D with antiretroviral treatment initiation and nutritional intervention in HIV-positive adults.

scientific article published on 8 November 2016

Change in serum 25-hydroxyvitamin D with antiretroviral treatment initiation and nutritional intervention in HIV-positive adults. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S0007114516003743
P698PubMed publication ID27821214

P50authorMette OlsenQ45324664
Markos TesfayeQ45324680
Pernille KæstelQ51436360
Henrik FriisQ85926034
Ole KirkQ102213445
Henrik KrarupQ42767014
Christian MølgaardQ43062546
P2093author name stringAlemseged Abdissa
Christian Ritz
Daniel Yilma
Kim F Michaelsen
Tsinuel Girma
Åse B Andersen
P2860cites workCross-Sectional and Longitudinal Evaluation of Body Composition in Men With HIV InfectionQ46103723
Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive personsQ46174328
Vitamin D insufficiency in a sunshine-sufficient area: southern EthiopiaQ46590069
Relative influences of sex, race, environment, and HIV infection on body composition in adultsQ46746167
Food insecurity among volunteer AIDS caregivers in Addis Ababa, Ethiopia was highly prevalent but buffered from the 2008 food crisisQ46917291
Weight and body composition in a cohort of HIV-positive men and women.Q47207979
The effect of antiretrovirals on vitamin D.Q54443730
Prevalence of Hypovitaminosis D and Factors Associated With Vitamin D Deficiency and Morbidity Among HIV-Infected Patients Enrolled in a Large Italian CohortQ56334704
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA studyQ57877133
Oral vitamin D supplementation has a lower bioavailability and reduces hypersecretion of parathyroid hormone and insulin resistance in obese Chinese malesQ64126927
Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general populationQ64129102
Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapyQ83227826
Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?Q83632365
The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicityQ28483688
Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug usersQ28538127
Effects of nutritional supplementation for HIV patients starting antiretroviral treatment: randomised controlled trial in EthiopiaQ33618988
25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settingsQ34076892
Effect of rifampicin and isoniazid on vitamin D metabolismQ34279202
Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapyQ34328579
High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trialQ34799320
Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, TanzaniaQ35063882
Vitamin D₃supplementation in Batswana children and adults with HIV: a pilot double blind randomized controlled trialQ35113182
Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settingsQ35154069
Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trialQ38442904
Vitamin D Deficiency in HIV-Infected Women on Antiretroviral Therapy Living in the TropicsQ38951904
Prevalence of vitamin D deficiency in HIV-positive, antiretroviral treatment-naïve patients in a single centre studyQ39019753
Ethnicity, Clothing Style, and Body Mass Index are Significant Predictors of Vitamin D Insufficiency in GermanyQ39116619
Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical settingQ39591171
High prevalence of vitamin D deficiency in HIV-infected adults: what are the future research questions?Q39673591
Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patientsQ40280595
Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patientsQ41644519
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).Q42242966
Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patientsQ42262759
Vitamin D deficiency in HIV-infected and -uninfected women in the United StatesQ42939810
Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase.Q43001305
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.Q43048034
Do nevirapine and efavirenz affect vitamin D homeostasis similarly?Q43584724
Body composition in HIV-infected womenQ43693522
Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern IndiaQ44007690
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs.Q44585706
P304page(s)1-8
P577publication date2016-11-08
P1433published inBritish Journal of NutritionQ4970206
P1476titleChange in serum 25-hydroxyvitamin D with antiretroviral treatment initiation and nutritional intervention in HIV-positive adults

Reverse relations

Q99557494Statistical analysis of continuous outcomes from parallel-arm randomized controlled trials in nutrition-a tutorialcites workP2860

Search more.